CN104856968A - 一种具有消栓通络作用的中药片剂及其制备方法 - Google Patents
一种具有消栓通络作用的中药片剂及其制备方法 Download PDFInfo
- Publication number
- CN104856968A CN104856968A CN201510275397.XA CN201510275397A CN104856968A CN 104856968 A CN104856968 A CN 104856968A CN 201510275397 A CN201510275397 A CN 201510275397A CN 104856968 A CN104856968 A CN 104856968A
- Authority
- CN
- China
- Prior art keywords
- radix
- chinese medicinal
- medicinal tablet
- weight portion
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 26
- 230000000694 effects Effects 0.000 title claims abstract description 18
- 208000007536 Thrombosis Diseases 0.000 title claims abstract description 7
- 239000003814 drug Substances 0.000 title abstract description 24
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 28
- 239000002994 raw material Substances 0.000 claims abstract description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 41
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 30
- 241000180649 Panax notoginseng Species 0.000 claims description 30
- 108090000790 Enzymes Proteins 0.000 claims description 28
- 102000004190 Enzymes Human genes 0.000 claims description 28
- 229940088598 enzyme Drugs 0.000 claims description 28
- 238000000034 method Methods 0.000 claims description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 25
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 24
- 239000000284 extract Substances 0.000 claims description 18
- 241000628997 Flos Species 0.000 claims description 15
- 239000009636 Huang Qi Substances 0.000 claims description 15
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 15
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 15
- 239000003795 chemical substances by application Substances 0.000 claims description 15
- 238000004132 cross linking Methods 0.000 claims description 15
- 239000001253 polyvinylpolypyrrolidone Substances 0.000 claims description 15
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 claims description 15
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 claims description 15
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 15
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 15
- 150000001875 compounds Chemical class 0.000 claims description 14
- 239000000706 filtrate Substances 0.000 claims description 14
- 235000019359 magnesium stearate Nutrition 0.000 claims description 12
- 238000002156 mixing Methods 0.000 claims description 12
- 108010059892 Cellulase Proteins 0.000 claims description 11
- 229940106157 cellulase Drugs 0.000 claims description 11
- 230000007062 hydrolysis Effects 0.000 claims description 11
- 238000006460 hydrolysis reaction Methods 0.000 claims description 11
- 239000000843 powder Substances 0.000 claims description 10
- 239000000341 volatile oil Substances 0.000 claims description 9
- 239000008187 granular material Substances 0.000 claims description 7
- 238000001256 steam distillation Methods 0.000 claims description 6
- 238000004064 recycling Methods 0.000 claims description 5
- 238000003809 water extraction Methods 0.000 claims description 5
- 239000007888 film coating Substances 0.000 claims description 4
- 238000009501 film coating Methods 0.000 claims description 4
- 239000012467 final product Substances 0.000 claims description 4
- 238000005469 granulation Methods 0.000 claims description 3
- 230000003179 granulation Effects 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 239000007779 soft material Substances 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 2
- 239000002245 particle Substances 0.000 claims description 2
- 238000005507 spraying Methods 0.000 claims description 2
- 238000003756 stirring Methods 0.000 claims description 2
- 239000004480 active ingredient Substances 0.000 abstract description 3
- 235000006533 astragalus Nutrition 0.000 abstract description 2
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 abstract 1
- 241000045403 Astragalus propinquus Species 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 abstract 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 abstract 1
- 235000009685 Crataegus X maligna Nutrition 0.000 abstract 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 abstract 1
- 235000009486 Crataegus bullatus Nutrition 0.000 abstract 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 abstract 1
- 235000009682 Crataegus limnophila Nutrition 0.000 abstract 1
- 235000004423 Crataegus monogyna Nutrition 0.000 abstract 1
- 240000000171 Crataegus monogyna Species 0.000 abstract 1
- 235000002313 Crataegus paludosa Nutrition 0.000 abstract 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 abstract 1
- 244000116484 Inula helenium Species 0.000 abstract 1
- 235000002598 Inula helenium Nutrition 0.000 abstract 1
- 241000112528 Ligusticum striatum Species 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 abstract 1
- 235000017276 Salvia Nutrition 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 241000219784 Sophora Species 0.000 abstract 1
- 229940116229 borneol Drugs 0.000 abstract 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 abstract 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 abstract 1
- SMDOOINVMJSDPS-UHFFFAOYSA-N Astragaloside Natural products C1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)OC2C(C(OC3C(C(O)C(O)C(CO)O3)O)C(O)C(CO)O2)O)=C1 SMDOOINVMJSDPS-UHFFFAOYSA-N 0.000 description 14
- QMNWISYXSJWHRY-XWJCTJPOSA-N astragaloside Chemical compound O1[C@H](C(C)(O)C)CC[C@]1(C)[C@@H]1[C@@]2(C)CC[C@]34C[C@]4(CC[C@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)CO4)O)C4(C)C)C4[C@@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)CC3[C@]2(C)C[C@@H]1O QMNWISYXSJWHRY-XWJCTJPOSA-N 0.000 description 14
- 238000002474 experimental method Methods 0.000 description 12
- 229940079593 drug Drugs 0.000 description 9
- 238000000605 extraction Methods 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 239000008727 tongluo Substances 0.000 description 6
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 238000011835 investigation Methods 0.000 description 5
- 239000012153 distilled water Substances 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- 206010008190 Cerebrovascular accident Diseases 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 208000006011 Stroke Diseases 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- 241001061264 Astragalus Species 0.000 description 1
- 235000010110 Astragalus glycyphyllos Nutrition 0.000 description 1
- 108090000145 Bacillolysin Proteins 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 206010008132 Cerebral thrombosis Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- 102000035092 Neutral proteases Human genes 0.000 description 1
- 108091005507 Neutral proteases Proteins 0.000 description 1
- 206010071299 Slow speech Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940031703 low substituted hydroxypropyl cellulose Drugs 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000004796 pathophysiological change Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 230000036632 reaction speed Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 239000013558 reference substance Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
组号 | 酶解温度 | 黄芪甲苷转移率% |
1 | 35℃ | 85.5 |
2 | 40℃ | 91.4 |
3 | 45℃ | 94.7 |
4 | 50℃ | 96.2 |
5 | 55℃ | 95.1 |
6 | 60℃ | 92.9 |
组号 | 酶解时间 | 黄芪甲苷转移率% |
1 | 0.5小时 | 91.6 |
2 | 1小时 | 96.1 |
3 | 1.5小时 | 96.5 |
4 | 2小时 | 96.2 |
组号 | 崩解剂 | 崩解时间(min) |
1 | —— | 23.5 |
2 | 羧甲基淀粉钠 | 22.6 |
3 | 交联羧甲基纤维素钠 | 19.1 |
4 | 低取代羟丙基纤维素 | 20.5 |
5 | 交联聚维酮 | 17.8 |
6 | 交联聚维酮+交联羧甲基纤维素钠(1:1) | 17.2 |
7 | 交联聚维酮+交联羧甲基纤维素钠(2:1) | 15.3 |
8 | 交联聚维酮+交联羧甲基纤维素钠(1:2) | 19.4 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510275397.XA CN104856968B (zh) | 2015-05-27 | 2015-05-27 | 一种具有消栓通络作用的中药片剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510275397.XA CN104856968B (zh) | 2015-05-27 | 2015-05-27 | 一种具有消栓通络作用的中药片剂及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104856968A true CN104856968A (zh) | 2015-08-26 |
CN104856968B CN104856968B (zh) | 2018-02-09 |
Family
ID=53903443
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510275397.XA Active CN104856968B (zh) | 2015-05-27 | 2015-05-27 | 一种具有消栓通络作用的中药片剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104856968B (zh) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105106151A (zh) * | 2015-09-16 | 2015-12-02 | 韩志强 | 一种接骨片及其制备方法 |
CN105106153A (zh) * | 2015-09-16 | 2015-12-02 | 韩志强 | 一种木瓜片 |
CN105168160A (zh) * | 2015-09-28 | 2015-12-23 | 韩志强 | 一种羚羊感冒片及其制备方法 |
CN105497175A (zh) * | 2015-12-31 | 2016-04-20 | 吉林紫鑫药业股份有限公司 | 一种用于舒筋活血散瘀止痛药物的制备方法 |
CN105497794A (zh) * | 2015-12-30 | 2016-04-20 | 平光制药股份有限公司 | 一种降血脂抗血栓温经活络的中药组合物及其制备方法 |
CN105561184A (zh) * | 2015-12-31 | 2016-05-11 | 吉林紫鑫药业股份有限公司 | 一种用于活血化瘀温经通络的药物组合物及其制备方法 |
CN107164164A (zh) * | 2017-07-16 | 2017-09-15 | 钱如贵 | 一种中药发酵酒的制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1579520A (zh) * | 2004-05-19 | 2005-02-16 | 吉林省东北亚药业股份有限公司 | 一种消栓通络的药物及其制备方法 |
CN1720988A (zh) * | 2005-07-29 | 2006-01-18 | 北京蓝贝望医药科技开发有限公司 | 消栓通络软胶囊及其制备方法 |
CN1868533A (zh) * | 2005-12-31 | 2006-11-29 | 浙江天一堂集团有限公司 | 中药消栓通络软胶囊及其制备方法 |
CN103495117A (zh) * | 2013-10-09 | 2014-01-08 | 南京正亮医药科技有限公司 | 一种消栓通络片的制备方法及应用 |
-
2015
- 2015-05-27 CN CN201510275397.XA patent/CN104856968B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1579520A (zh) * | 2004-05-19 | 2005-02-16 | 吉林省东北亚药业股份有限公司 | 一种消栓通络的药物及其制备方法 |
CN1720988A (zh) * | 2005-07-29 | 2006-01-18 | 北京蓝贝望医药科技开发有限公司 | 消栓通络软胶囊及其制备方法 |
CN1868533A (zh) * | 2005-12-31 | 2006-11-29 | 浙江天一堂集团有限公司 | 中药消栓通络软胶囊及其制备方法 |
CN103495117A (zh) * | 2013-10-09 | 2014-01-08 | 南京正亮医药科技有限公司 | 一种消栓通络片的制备方法及应用 |
Non-Patent Citations (1)
Title |
---|
陈丛瑾等: "植物挥发油的提取技术研究进展", 《食品研究与开发》 * |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105106151A (zh) * | 2015-09-16 | 2015-12-02 | 韩志强 | 一种接骨片及其制备方法 |
CN105106153A (zh) * | 2015-09-16 | 2015-12-02 | 韩志强 | 一种木瓜片 |
CN105106153B (zh) * | 2015-09-16 | 2018-01-05 | 韩志强 | 一种木瓜片 |
CN105106151B (zh) * | 2015-09-16 | 2018-03-23 | 韩志强 | 一种接骨片及其制备方法 |
CN105168160A (zh) * | 2015-09-28 | 2015-12-23 | 韩志强 | 一种羚羊感冒片及其制备方法 |
CN105168160B (zh) * | 2015-09-28 | 2018-10-19 | 韩志强 | 一种羚羊感冒片及其制备方法 |
CN105497794A (zh) * | 2015-12-30 | 2016-04-20 | 平光制药股份有限公司 | 一种降血脂抗血栓温经活络的中药组合物及其制备方法 |
CN105497175A (zh) * | 2015-12-31 | 2016-04-20 | 吉林紫鑫药业股份有限公司 | 一种用于舒筋活血散瘀止痛药物的制备方法 |
CN105561184A (zh) * | 2015-12-31 | 2016-05-11 | 吉林紫鑫药业股份有限公司 | 一种用于活血化瘀温经通络的药物组合物及其制备方法 |
CN107164164A (zh) * | 2017-07-16 | 2017-09-15 | 钱如贵 | 一种中药发酵酒的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN104856968B (zh) | 2018-02-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104856968A (zh) | 一种具有消栓通络作用的中药片剂及其制备方法 | |
CN103961465A (zh) | 一种明目安神组合物及其制备方法 | |
CN105079491A (zh) | 一种铁皮石斛西洋参胶囊及其制备方法 | |
CN102309565B (zh) | 改善睡眠的中药组合物及其制备方法 | |
CN102139090A (zh) | 一种用于治疗抑郁症的中药组合物及其制备方法和应用 | |
CN100367940C (zh) | 妇宁康薄膜衣片的制备方法 | |
CN113209166A (zh) | 一种含烟酰胺单核苷酸的抗衰老中药组合物及其制备方法 | |
CN101347605B (zh) | 一种用于治疗痛风的中药组合物及其制备方法和用途 | |
CN102961584B (zh) | 一种抗疲劳的中药组合物及其制备方法和应用 | |
CN102805836B (zh) | 一种治疗原发性肝癌的中药组合物及其制备方法 | |
CN100484539C (zh) | 一种具有降血糖作用的功能食品及其制备方法 | |
CN102357151B (zh) | 一种延缓衰老的中药组合物及其制备工艺 | |
CN105456390A (zh) | 一种用于心血管内科临床的混成制剂及制备方法 | |
CN101642480A (zh) | 一种具有清热作用的田七花叶***片及其制备方法 | |
CN100455300C (zh) | 野生猕猴桃复方吞咽片及其制备方法 | |
CN103070893A (zh) | 马齿苋制备治疗老年性痴呆的药物 | |
CN105535032A (zh) | 一种松露多糖的提取方法及松露保健品 | |
CN105031290A (zh) | 一种复方铁皮石斛胶囊及其制备方法 | |
CN103919972B (zh) | 一种抗疲劳的药物组合物及其制备方法和应用 | |
CN107496876A (zh) | 一种消栓通脉中药制剂及其制备方法 | |
CN105055515A (zh) | 一种含有丹参的药物组合物及其制备方法 | |
CN105168160A (zh) | 一种羚羊感冒片及其制备方法 | |
CN105106764A (zh) | 一种用于治疗妊娠呕吐的药物制剂 | |
CN103054920A (zh) | 预防和治疗肥胖的马齿苋 | |
CN105169064A (zh) | 一种用于美白皮肤的药物制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
EXSB | Decision made by sipo to initiate substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20191209 Address after: 064400 No. 2966, modern equipment manufacturing industry cluster, Qian'an City, Tangshan City, Hebei Province Patentee after: Hebei Baishan Pharmaceutical Co.,Ltd. Address before: 063000 Hebei Province, Tangshan City Road North North West Road No. 18 Patentee before: Han Zhiqiang |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Traditional Chinese medicine tablet with effects of removing thrombus and dredging collaterals and preparation method thereof Effective date of registration: 20200312 Granted publication date: 20180209 Pledgee: Bank of Cangzhou Limited by Share Ltd. Tangshan branch Pledgor: Hebei Baishan Pharmaceutical Co.,Ltd. Registration number: Y2020980000651 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20210219 Granted publication date: 20180209 Pledgee: Bank of Cangzhou Limited by Share Ltd. Tangshan branch Pledgor: Hebei Baishan Pharmaceutical Co.,Ltd. Registration number: Y2020980000651 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: The invention relates to a traditional Chinese medicine tablet with the function of eliminating thrombus and dredging collaterals and a preparation method thereof Effective date of registration: 20220107 Granted publication date: 20180209 Pledgee: Bank of Cangzhou Limited by Share Ltd. Tangshan branch Pledgor: Hebei Baishan Pharmaceutical Co.,Ltd. Registration number: Y2022980000150 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230717 Granted publication date: 20180209 Pledgee: Bank of Cangzhou Limited by Share Ltd. Tangshan branch Pledgor: Hebei Baishan Pharmaceutical Co.,Ltd. Registration number: Y2022980000150 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A traditional Chinese medicine tablet with thrombolytic and unblocking effects and its preparation method Effective date of registration: 20231222 Granted publication date: 20180209 Pledgee: Bank of Cangzhou Limited by Share Ltd. Tangshan branch Pledgor: Hebei Baishan Pharmaceutical Co.,Ltd. Registration number: Y2023110000547 |